Osmosteril (Mannitol)

Mannitol, the active ingredient in Osmosteril, is an osmotic diuretic presented as a sterile powder for intravenous infusion use. It is employed to reduce intracranial pressure and promote diuresis in patients requiring renal support. GNH USA supplies Osmosteril as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

GNH USA supplies Osmosteril as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

Osmosteril is an osmotic diuretic that acts on renal water handling and intracranial fluid dynamics. - Acute kidney injury: facilitates osmotic diuresis to aid fluid removal. - Cerebral edema: lowers intracranial pressure by drawing fluid from brain tissue. - Glaucoma surgery: used intra‑operatively to maintain ocular hypotony. - Intra‑operative renal protection: provides renal perfusion during brief periods of ischemia. - Hyperosmolar therapy: serves as a hyperosmolar agent in selected emergency settings.

Mannitol may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: mild to moderate discomfort often reported after infusion. - Nausea: occasional gastrointestinal upset. - Electrolyte imbalance: shifts in sodium, potassium or calcium levels. - Transient hypotension: brief drop in blood pressure during rapid infusion. - Flank pain: discomfort in the kidney area. - Polyuria: increased urine output.

Serious or Rare Side Effects: - Acute kidney injury: worsening renal function in susceptible patients. - Pulmonary edema: fluid accumulation in the lungs. - Severe electrolyte disturbances: hypernatremia or hyponatremia. - Anaphylactoid reaction: rare hypersensitivity with rash or bronchospasm. - Hemolysis: rare red‑cell destruction. - Metabolic acidosis: disturbance in acid‑base balance.

When using Osmosteril, clinicians should assess patient risk factors and monitor relevant parameters. - Renal function: evaluate baseline creatinine and glomerular filtration rate. - Fluid balance: track input‑output charts to avoid overload. - Electrolytes: monitor serum sodium, potassium and calcium levels. - Cardiovascular status: watch for hypotension during rapid infusion. - Pregnancy and lactation: consider risk‑benefit ratio before use. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Mannitol may interact with several concomitant medications, altering efficacy or safety.

Major Interactions (Avoid): - Loop diuretics: combined use can precipitate profound electrolyte loss. - Nephrotoxic antibiotics: increased risk of renal impairment. - Vasopressors: may reduce the intended osmotic effect on cerebral pressure.

Moderate Interactions (Monitor Closely): - ACE inhibitors: potential additive effect on blood pressure. - Antihypertensive agents: may enhance hypotensive response. - Lithium: altered renal clearance may increase lithium levels.